Cargando…
In silico designing of a novel epitope-based candidate vaccine against Streptococcus pneumoniae with introduction of a new domain of PepO as adjuvant
BACKGROUND: Streptococcus pneumoniae is the leading reason for invasive diseases including pneumonia and meningitis, and also secondary infections following viral respiratory diseases such as flu and COVID-19. Currently, serotype-dependent vaccines, which have several insufficiency and limitations,...
Autores principales: | Bahadori, Zohreh, Shafaghi, Mona, Madanchi, Hamid, Ranjbar, Mohammad Mehdi, Shabani, Ali Akbar, Mousavi, Seyed Fazlollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440865/ https://www.ncbi.nlm.nih.gov/pubmed/36059030 http://dx.doi.org/10.1186/s12967-022-03590-6 |
Ejemplares similares
-
Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains
por: Shafaghi, Mona, et al.
Publicado: (2023) -
A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach
por: Shafaghi, Mona, et al.
Publicado: (2023) -
PepO and CppA modulate Streptococcus sanguinis susceptibility to complement immunity and virulence
por: Alves, Lívia A., et al.
Publicado: (2023) -
PepO is a target of the two-component systems VicRK and CovR required for systemic virulence of Streptococcus mutans
por: Alves, Lívia A., et al.
Publicado: (2020) -
In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A
por: Afshari, Elnaz, et al.
Publicado: (2023)